MRD-driven strategies and novel immunotherapies for multiple myeloma

Bookmark and Share
Published: 25 Oct 2021
Views: 684
Rating:
Save
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia

Prof Simon Harrison speaks to ecancer about MRD-driven strategies and novel immunotherapies for multiple myeloma.

He talks about his presentation at MyKE Myeloma 2021.

Initially, Prof Harrison talks about the MRD-driven strategies in NDMM.

He then explains some of the novel immunotherapies for multiple myelomas.

Prof Harrison concludes by discussing bispecific antibodies, CAR T therapies and ADCs.

 

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.